As of 2026-03-15, the Relative Valuation of Adverum Biotechnologies Inc (ADVM) is (85.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.36 USD, the upside of Adverum Biotechnologies Inc based on Relative Valuation is -2064.5%.
The range of the Relative Valuation is (75.99) - (90.03) USD.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.8x | 21.1x |
| Forward P/E multiples | 18.1x - 22.4x | 21.6x |
| Fair Price | (75.99) - (90.03) | (85.65) |
| Upside | -1842.8% - -2164.8% | -2064.5% |
| Date | P/E |